Advertisement · 728 × 90
#
Hashtag
#abiraterone
Advertisement · 728 × 90
Preview
Abiraterone: Complete Guide for Prostate Cancer Patients in the Philippines Prostate cancer remains one of the most common cancers affecting men worldwide. The Philippines now offers advanced therapy Abiraterone, which has improved treatment results. The blog presents an e…

Abiraterone: Complete Guide for Prostate Cancer Patients in the Philippines

oddwaypharmaceuticalexporter.wordpress.com/2026/03/31/a...

#Abiraterone #AbirateroneAcetate #Healthcare #Blog #ProstateCancer #MedicineSupplierPhilippines #CancerTreatment

1 0 0 0
Preview
NICE relents, ending postcode access to prostate cancer drug Men in England with high-risk prostate cancer will soon be able to get treatment with a drug available in Scotland and Wales for almost three years.

#prostatecancer #menshealth #NICE #NHS #prostatecancerdrug #highriskprostatecancer #ProstateCancerUK #abiraterone #JnJ #Zytiga #brandedpharmaceuticals #generics #HSPC #NICEcosteffectivenesscalculations #advancedprostatecancer #prostatecancerscreening #PSAtesting #BRCAgenevariants
zurl.co/ZNxJT

0 0 0 0
Post image

In a study using real-world data, Black patients with #mCSPC treated with #apalutamide achieved earlier and higher deep PSA responses than those receiving #abiraterone acetate, suggesting improved outcomes in an understudied population. jheor.org/article/151273 #HEOR #prostatecancer

0 0 0 0
Preview
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer - OncoDaily FDA approves niraparib plus abiraterone and prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer based on AMPLITUDE trial data.

FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

@fda.gov

oncodaily.com/fda-approval...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Niraparib #Abiraterone #BRCA2 #ProstateCancer #MCSPC

3 0 0 0
Economic Evaluation of a Novel MicroRNA-Based Assay to Determine Risk of Late Genitourinary Radiation Toxicity in Patients With Prostate Cancer

Economic Evaluation of a Novel MicroRNA-Based Assay to Determine Risk of Late Genitourinary Radiation Toxicity in Patients With Prostate Cancer

In a real-world study of Black patients with metastatic prostate cancer, #apalutamide produced earlier and deeper PSA responses than #abiraterone acetate, highlighting potential clinical benefits in an understudied population. jheor.org/article/146844 #HEOR #ProstateCancer #BlackPatients

1 0 0 0

From the discovery and subsequent development of #Abiraterone in the 1990s – the first treatment ever shown to be effective in men with advanced prostate cancer -

1 0 1 0
"Significant shift" as NICE widens prostate cancer drug use NICE has changed unpopular guidance on abiraterone for hormone-sensitive prostate cancer after the entry of generics into the UK market

#menshealth #NICE #prostatecancer #hormonesensitiveprostatecancer #HSPC #abiraterone #JnJ #Zytiga #brandedpharmaceuticals #NICEguidance #advancedHSPC #androgendeprivationtherapy #ADT #Bayer #Nubeqa #Astellas #Xtandi #Erleada #genericmedicines #ProstateCancerUK
zurl.co/fzdbT

0 0 0 0

J’ai du bol, mon oncologue a inscrit l’ #Abiraterone sur mon plan de traitement. #moncrabe

0 0 0 0
Preview
Effect of Prednisone Dosing on Mineralocorticoid-Related Side Effects With Abiraterone in Prostate Cancer | JCO Oncology Practice PURPOSEAbiraterone use for prostate cancer can cause mineralocorticoid excess syndrome (MES; eg, hypertension and hypokalemia). Prednisone mitigates these effects; however, the optimal dose level is u...

Usar prednisona 5 mg BID reduce el riesgo de hipertensión o hipokalemia en pacientes con cáncer de próstata que reciben abiraterone, sin impactos metabólicos en el IMC o la hiperglucemia #prednisone #abiraterone #PCa ascopubs.org/doi/abs/10.1...

0 0 0 0
Preview
Men denied life-extending prostate cancer drug on NHS in England NHS England says it cannot afford to offer abiraterone, which is available in Scotland and Wales.

HealthMatters: This is extremely sad and more or less tells us where were at with the #NHS in England!

#MensHealth #Cancer #ProstateCancer #Prostate #abiraterone #SymeBros

www.bbc.co.uk/news/article...

0 0 0 1
Preview
Men denied life-extending prostate cancer drug on NHS in England NHS England says it cannot afford to offer abiraterone, which is available in Scotland and Wales.

HealthMatters: This is extremely sad and more or less tells us where were at with the #NHS in England!

#MensHealth #Cancer #ProstateCancer #Prostate #abiraterone #SymeBros

www.bbc.co.uk/news/article...

0 0 0 0